Literature DB >> 24160326

Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.

Fang Qi1, Gordon Okimoto, Sandro Jube, Andrea Napolitano, Harvey I Pass, Rozalia Laczko, Richard M Demay, Ghazal Khan, Maarit Tiirikainen, Caterina Rinaudo, Alessandro Croce, Haining Yang, Giovanni Gaudino, Michele Carbone.   

Abstract

Malignant mesothelioma is strongly associated with asbestos exposure. Among asbestos fibers, crocidolite is considered the most and chrysotile the least oncogenic. Chrysotile accounts for more than 90% of the asbestos used worldwide, but its capacity to induce malignant mesothelioma is still debated. We found that chrysotile and crocidolite exposures have similar effects on human mesothelial cells. Morphological and molecular alterations suggestive of epithelial-mesenchymal transition, such as E-cadherin down-regulation and β-catenin phosphorylation followed by nuclear translocation, were induced by both chrysotile and crocidolite. Gene expression profiling revealed high-mobility group box-1 protein (HMGB1) as a key regulator of the transcriptional alterations induced by both types of asbestos. Crocidolite and chrysotile induced differential expression of 438 out of 28,869 genes interrogated by oligonucleotide microarrays. Out of these 438 genes, 57 were associated with inflammatory and immune response and cancer, and 14 were HMGB1 targeted genes. Crocidolite-induced gene alterations were sustained, whereas chrysotile-induced gene alterations returned to background levels within 5 weeks. Similarly, HMGB1 release in vivo progressively increased for 10 or more weeks after crocidolite exposure, but returned to background levels within 8 weeks after chrysotile exposure. Continuous administration of chrysotile was required for sustained high serum levels of HMGB1. These data support the hypothesis that differences in biopersistence influence the biological activities of these two asbestos fibers.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24160326      PMCID: PMC3814524          DOI: 10.1016/j.ajpath.2013.07.029

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts.

Authors:  R A MacCorkle; S D Slattery; D R Nash; B R Brinkley
Journal:  Cell Motil Cytoskeleton       Date:  2006-10

2.  Asbestos use and carcinogenicity in Germany and a comparison with animal studies.

Authors:  F Pott
Journal:  Ann Occup Hyg       Date:  1994-08

3.  Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

Authors:  Haining Yang; Zeyana Rivera; Sandro Jube; Masaki Nasu; Pietro Bertino; Chandra Goparaju; Guido Franzoso; Michael T Lotze; Thomas Krausz; Harvey I Pass; Marco E Bianchi; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.

Authors:  Sandro Jube; Zeyana S Rivera; Marco E Bianchi; Amy Powers; Ena Wang; Ian Pagano; Harvey I Pass; Giovanni Gaudino; Michele Carbone; Haining Yang
Journal:  Cancer Res       Date:  2012-05-02       Impact factor: 12.701

Review 5.  The epidemiology of mesothelioma.

Authors:  Mark Britton
Journal:  Semin Oncol       Date:  2002-02       Impact factor: 4.929

6.  Cadherins, catenins and APC in pleural malignant mesothelioma.

Authors:  A S Abutaily; J E Collins; W R Roche
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

7.  Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008.

Authors:  S Jane Henley; Theodore C Larson; Manxia Wu; Vinicius C S Antao; Mary Lewis; Germania A Pinheiro; Christie Eheman
Journal:  Int J Occup Environ Health       Date:  2013 Jan-Mar

8.  The role of the receptor for advanced glycation end-products in lung fibrosis.

Authors:  Mei He; Hiroshi Kubo; Kota Ishizawa; Ahmed E Hegab; Yasuhiko Yamamoto; Hiroshi Yamamoto; Mutsuo Yamaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-10-19       Impact factor: 5.464

9.  Mesothelioma in pet dogs associated with exposure of their owners to asbestos.

Authors:  L T Glickman; L M Domanski; T G Maguire; R R Dubielzig; A Churg
Journal:  Environ Res       Date:  1983-12       Impact factor: 6.498

10.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

View more
  45 in total

Review 1.  Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.

Authors:  Zhongjian Chen; Giovanni Gaudino; Harvey I Pass; Michele Carbone; Haining Yang
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 2.  In vitro experimental models of mesothelioma revisited.

Authors:  Anand Singh; Nathanael Pruett; Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.

Authors:  Salih A Emri
Journal:  Ann Transl Med       Date:  2017-06

Review 4.  Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure.

Authors:  Clementina Mesaros; Andrew J Worth; Nathaniel W Snyder; Melpo Christofidou-Solomidou; Anil Vachani; Steven M Albelda; Ian A Blair
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

Review 5.  Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas.

Authors:  Lynnette Fernandez-Cuesta; Lise Mangiante; Nicolas Alcala; Matthieu Foll
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

Review 6.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

Review 7.  Progress in the Management of Malignant Pleural Mesothelioma in 2017.

Authors:  Amanda J McCambridge; Andrea Napolitano; Aaron S Mansfield; Dean A Fennell; Yoshitaka Sekido; Anna K Nowak; Thanyanan Reungwetwattana; Weimin Mao; Harvey I Pass; Michele Carbone; Haining Yang; Tobias Peikert
Journal:  J Thorac Oncol       Date:  2018-03-08       Impact factor: 15.609

8.  Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis.

Authors:  Lucia Cottone; Annalisa Capobianco; Chiara Gualteroni; Antonella Monno; Isabella Raccagni; Silvia Valtorta; Tamara Canu; Tiziano Di Tomaso; Angelo Lombardo; Antonio Esposito; Rosa Maria Moresco; Alessandro Del Maschio; Luigi Naldini; Patrizia Rovere-Querini; Marco E Bianchi; Angelo A Manfredi
Journal:  Oncoimmunology       Date:  2016-01-08       Impact factor: 8.110

Review 9.  Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.

Authors:  Hui Liu; Licun Wu; Kai Ji; Wei Wang
Journal:  Tumour Biol       Date:  2015-09-11

Review 10.  Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.

Authors:  Angela Bononi; Andrea Napolitano; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  Expert Rev Respir Med       Date:  2015-08-26       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.